Aristeia Capital’s DocGo DCGO Stock Holding History

Aristeia Capital’s Portfolio DCGO Stock Details DCGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-262,674	Closed	-$2.59M	–	495
2021 Q1	$2.59M	Buy	+262,674	New	+$2.69M	0.05%	321

Other funds holding DCGO

Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

ACA

Arena Capital Advisors Los Angeles, California $200M AUM 23.6% 1-Year Est. Return

RCM

Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

MCM

Moore Capital Management New York $4.92B AUM 35.41% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

BCM

BlueCrest Capital Management St Helier, Jersey $1.69B AUM 20.01% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

Aristeia Capital's DCGO Position: Q2 2021 in Review

Aristeia Capital sold out of DocGo (DCGO) in Q2 2021, closing a stake of 262,674 shares — an estimated $2.59M sold.

Aristeia Capital first reported a position in DCGO in Q1 2021 and held it in 1 quarter. The position peaked at $2.59M in Q1 2021. 38 funds tracked by Wall St. Rank hold DCGO as of Q2 2021.

Aristeia Capital reported no remaining DocGo position as of Q2 2021 after selling out during the quarter.
Aristeia Capital sold 262,674 DocGo shares in Q2 2021, an estimated $2.59M.
Aristeia Capital first reported a position in DocGo in Q1 2021 and held it in 1 quarter.
Aristeia Capital's DocGo position peaked at $2.59M in Q1 2021.
38 funds tracked by Wall St. Rank held DocGo as of Q2 2021.

Based on Aristeia Capital's 13F filing for Q2 2021, filed 16 Aug 2021.